Refine
Document Type
- Article (53)
Language
- English (53)
Has Fulltext
- yes (53)
Is part of the Bibliography
- no (53)
Keywords
- - (22)
- Alzheimer’s disease (4)
- cerebrospinal fluid (4)
- free light chain kappa (4)
- metabolomics (4)
- periodontitis (4)
- immunoglobulin (3)
- obesity (3)
- protein analytic (3)
- Brain-derived neurotrophic factor (2)
- CSF (2)
- Cardiovascular disease (2)
- Depression (2)
- Obesity (2)
- Vitamin D (2)
- biomarkers (2)
- epidemiology (2)
- 3,5-Diiodothyronine (1)
- 6-min-walk-test (1)
- APOE ε4 (1)
- Acute decompensated heart failure (1)
- Albuminuria (1)
- Apolipoprotein concentration (1)
- BDNF (1)
- BMD (1)
- Brain health (1)
- CCR2 (1)
- Chronic non-communicable diseases (1)
- Congestion (1)
- Cortisol (1)
- Cytokines (1)
- Data and biomaterial collection (1)
- Dyslipidemia (1)
- Energy mobilization (1)
- Epidemiology (1)
- Estimated glomerular filtration rate (1)
- GWA (1)
- GWAS (1)
- Gelatinase A (1)
- German Centre for Cardiovascular Research (1)
- Glucocorticoid receptor (1)
- HDL (1)
- HLA (1)
- Heart-liver axis (1)
- Hippocampus (1)
- Immunometabolism (1)
- Individualization (1)
- Inferior vena cava (1)
- Inflammation (1)
- Inflammatory biomarkers (1)
- Iodine (1)
- KREC (1)
- Kidney disease (1)
- LDL (1)
- Left ventricular geometry and function (1)
- Left ventricular hypertrophy (1)
- Left ventricular mass (1)
- Lipid metabolism (1)
- Lipidomics (1)
- Lipolysis (1)
- Lipoprotein particles (1)
- Lipoprotein subclasses (1)
- MCP-1 (1)
- MDD (1)
- MHC (1)
- MMP2 (1)
- MODS (1)
- MRI (1)
- Measurement error (1)
- NAFLD (1)
- NGS (1)
- NMR metabolomics (1)
- NMR spectroscopy (1)
- NR3C1 (1)
- NT‐proBNP (1)
- Nuclear magnetic resonance spectroscopy (1)
- PID (1)
- Prevention of cardiovascular diseases (1)
- Prevention of metabolic diseases (1)
- RareScreen (1)
- Research platform (1)
- Residual risk (1)
- SCID (1)
- SHIP (1)
- SiMoA (1)
- Single nucleotide polymorphisms (1)
- Sleep (1)
- Slow wave sleep (1)
- Small dense LDL (1)
- Soluble APRIL (1)
- Soluble BAFF (1)
- Spermidine (1)
- Sphingosine-1-phosphate (1)
- Standardisation (1)
- Staphyloccus aureus (1)
- Study of Health in Pomerania (1)
- Systemic infection (1)
- TNF (1)
- TREC (1)
- TREML2 (1)
- TSH (1)
- TSST-1 (1)
- The Study of Health in Pomerania (1)
- Thyroglobulin (1)
- Thyroid (1)
- Thyroid hormone (1)
- Thyroid imaging (1)
- Thyroid-stimulating hormone (1)
- Total testosterone (1)
- Trigonelline (1)
- Ultrasound (1)
- Urine metabolome (1)
- VLDL (1)
- Variability (1)
- Verbal memory (1)
- Z-score standardization (1)
- abuse (1)
- acute pancreatitis (1)
- agreement (1)
- alpha diversity (1)
- amyloid beta (1)
- analytical measurements (1)
- anthropometry (1)
- antibody (1)
- antibody response (1)
- apolipoprotein E (1)
- apparently healthy (1)
- area deprivation (1)
- artificial blood contamination (1)
- artificial blood contamination; (1)
- bacteria (1)
- benzoate metabolism (1)
- beta coefficient (1)
- bias (1)
- biological aging (1)
- biomarker (1)
- blood cell metabolism (1)
- blood count (1)
- body weights and measures (1)
- bone quality (1)
- bone remodelling (1)
- bone turnover marker (1)
- brain atrophy (1)
- cardiorespiratory exercise capacity (1)
- cardiorespiratory fitness (1)
- cardiovascular diseas (1)
- cognition (1)
- cognitive function (1)
- cohort study (1)
- complete blood count (1)
- cortical thickness (1)
- cortisol (1)
- depresion (1)
- depression (1)
- diagnostic techniques and procedures (1)
- directed acyclic graphs (1)
- disease-modifying therapy (1)
- edentulism (1)
- education (1)
- estimated bone mineral density (1)
- exercise (1)
- fT3 (1)
- fT4 (1)
- fatigue (1)
- gene expression (1)
- general population (1)
- heart failure with preserved ejection fraction (1)
- hepatic steatosis (1)
- hippocampal volume (1)
- immune system (1)
- immunoglobulin synthesis (1)
- imprecision (1)
- income (1)
- individualized medicine (1)
- inflammation (1)
- iron surrogates (1)
- laboratory parameters (1)
- laboratory workflow (1)
- large cohort data (1)
- lipid profile (1)
- lipoprotein profile (1)
- lipoprotein profiling (1)
- long COVID (1)
- longitudinal cohort study (1)
- macrovascular disease (1)
- measurement error (1)
- mediatation (1)
- mediation (1)
- memory (1)
- metabolic syndrome (1)
- metabolism (1)
- metabolome (1)
- metrological controls (1)
- miRNA (1)
- microbiome (1)
- monocytes (1)
- multiple sclerosis (1)
- neglect (1)
- neurodegeneration (1)
- neurofilament (1)
- newborn screening (1)
- oligoclonal IgG (1)
- oral contraceptives (1)
- pathogen-specific IgG (1)
- personalized medicine (1)
- phenotyping (1)
- physical function (1)
- population-based imaging (1)
- population-based studies (1)
- population‐based study (1)
- post-COVID-19-syndrome (1)
- prediction modelling (1)
- prognostic factors (1)
- psychological profile (1)
- quality control (1)
- radiomics (1)
- rehabilitation (1)
- rs3747742 (1)
- rs56149945 (1)
- self-report (1)
- sepsis (1)
- serology (1)
- serum markers (1)
- sex differences (1)
- sex-specific (1)
- sleep disorders (1)
- spermidine (1)
- spleen volume (1)
- superantigen (1)
- thyroid (1)
- tooth loss (1)
- toxic shock syndrome (1)
- trauma (1)
- uncertainty of measurement (1)
- white matter hyperintensities (1)
- white matter hyperintensity (1)
- whole-body magnetic resonance imaging (1)
Institute
- Institut für Klinische Chemie und Laboratoriumsmedizin (12)
- Institut für Community Medicine (9)
- Kliniken und Polikliniken für Innere Medizin (9)
- Klinik für Psychiatrie und Psychotherapie (8)
- Klinik und Poliklinik für Neurologie (4)
- Institut für Biochemie (3)
- Institut für Pharmakologie (3)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie (2)
- Poliklinik für Zahnerhaltung, Parodontologie und Endodontologie (2)
- Friedrich-Loeffler-Institut für Medizinische Mikrobiologie (1)
Publisher
- MDPI (14)
- Wiley (7)
- Frontiers Media S.A. (6)
- Nature Publishing Group (6)
- S. Karger AG (5)
- Springer Nature (5)
- SAGE Publications (4)
- BioMed Central (BMC) (2)
- AO Research Institute Davos (1)
- BioScientifica (1)
Deteriorations in slow wave sleep (SWS) have been linked to brain aging and Alzheimer’s disease (AD), possibly due to its key role in clearance of amyloid-beta and tau (Aß/tau), two pathogenic hallmarks of AD. Spermidine administration has been shown to improve sleep quality in animal models. So far, the association between spermidine levels in humans and parameters of SWS physiology are unknown but may be valuable for therapeutic strategies. Data from 216 participants (age range 50–81 years) of the population-based Study of Health in Pomerania TREND were included in our analysis. We investigated associations between spermidine plasma levels, key parameters of sleep macroarchitecture and microarchitecture that were previously associated with AD pathology, and brain health measured via a marker of structural brain atrophy (AD score). Higher spermidine levels were significantly associated with lower coupling between slow oscillations and spindle activity. No association was evident for SWS, slow oscillatory, and spindle activity throughout non-rapid eye movement sleep. Furthermore, elevated spermidine blood levels were significantly associated with a higher AD score, while sleep markers revealed no association with AD score. The association between higher spermidine levels and brain health was not mediated by coupling between slow oscillations and spindle activity. We report that higher spermidine blood levels are associated not only with deteriorated brain health but also with less advantageous markers of sleep quality in older adults. Future studies need to evaluate whether sleep, spermidine, and Aß/tau deposition are interrelated and whether sleep may play a mediating role.
Introduction
Supplementation with spermidine may support healthy aging, but elevated spermidine tissue levels were shown to be an indicator of Alzheimer's disease (AD).
Methods
Data from 659 participants (age range: 21–81 years) of the population-based Study of Health in Pomerania TREND were included. We investigated the association between spermidine plasma levels and markers of brain aging (hippocampal volume, AD score, global cortical thickness [CT], and white matter hyperintensities [WMH]).
Results
Higher spermidine levels were significantly associated with lower hippocampal volume (ß = −0.076; 95% confidence interval [CI]: −0.13 to −0.02; q = 0.026), higher AD score (ß = 0.118; 95% CI: 0.05 to 0.19; q = 0.006), lower global CT (ß = −0.104; 95% CI: −0.17 to −0.04; q = 0.014), but not WMH volume. Sensitivity analysis revealed no substantial changes after excluding participants with cancer, depression, or hemolysis.
Discussion
Elevated spermidine plasma levels are associated with advanced brain aging and might serve as potential early biomarker for AD and vascular brain pathology.
Objective
Acute pancreatitis (AP) is an inflammatory disorder, the severe form of which is burdened with multi-organ dysfunction and high mortality. The pathogenesis of life –threatening organ complications, such as respiratory and renal failure, is unknown.
Design
Organ dysfunction was investigated in a mouse model of AP. The influence of monocytes and neutrophils on multi organ dysfunction syndrome (MODS) was investigated in vivo by antibody depletion. Using real-time-fluorescence and deformability-cytometry (RT-DC) analysis we determined the mechanical properties of neutrophils and monocytes during AP. Furthermore, blood samples of pancreatitis patients were used to characterize severity-dependent chemokine profiles according to the revised Atlanta classification.
Results
Similar to AP in humans, severe disease in the mouse model associates with organ dysfunction mainly of lung and kidney, which is triggered by a mobilisation of Ly6g-/CD11b+/Ly6c hi monocytes, but not of Ly6g+/CD11b+ neutrophils. Monocyte depletion by anti-CCR2 antibody treatment ameliorated lung function (oxygen consumption) without interfering with the systemic immune response. RT-DC analysis of circulation monocytes showed a significant increase in cell size during SAP, but without a compensatory increase in elasticity. Patient chemokine profiles show a correlation of AP severity with monocyte attracting chemokines like MCP-1 or MIG and with leukocyte mobilisation.
Conclusion
In AP, the physical properties of mobilized monocytes, especially their large size, result in an obstruction of the fine capillary systems of the lung and of the kidney glomeruli. A selective depletion of monocytes may represent a treatment strategy for pancreatitis as well as for other inflammation-related disorders.
Life-threatening toxic shock syndrome is often caused by the superantigen toxic shock syndrome toxin-1 (TSST-1) produced by Staphylococcus aureus. A well-known risk factor is the lack of neutralizing antibodies. To identify determinants of the anti-TSST-1 antibody response, we examined 976 participants of the German population-based epidemiological Study of Health in Pomerania (SHIP-TREND-0). We measured anti-TSST-1 antibody levels, analyzed the colonization with TSST-1-encoding S. aureus strains, and performed a genome-wide association analysis of genetic risk factors. TSST-1-specific serum IgG levels varied over a range of 4.2 logs and were elevated by a factor of 12.3 upon nasal colonization with TSST-1-encoding S. aureus. Moreover, the anti-TSST-1 antibody levels were strongly associated with HLA class II gene loci. HLA-DRB1*03:01 and HLA-DQB1*02:01 were positively, and HLA-DRB1*01:01 as well as HLA-DQB1*05:01 negatively associated with the anti-TSST-1 antibody levels. Thus, both toxin exposure and HLA alleles affect the human antibody response to TSST-1.
The hypothalamus–pituitary–adrenal axis is the main physiological stress response system and regulating the release of cortisol. The two corticoid receptors encoded by the genes NR3C1 and NR3C2 are the main players in regulating the physiological response to cortisol. This biological system has been linked to neurocognitive processes and memory, yet the mechanisms remain largely unclear. In two independent general population studies (SHIP, total sample size > 5500), we aim to diseantangle the effects of genetic variation, gene expression and cortisol on verbal memory and memory associated brain volume. Especially for NR3C1 results exhibited a consistent pattern of direct an interactive effects. All three biological layers, genetic variation (rs56149945), gene expression for NR3C1 and cortisol levels, were directly associated with verbal memory. Interactions between these components showed significant effects on verbal memory as well as hippocampal volume. For NR3C2 such a complex association pattern could not be observed. Our analyses revealed that different components of the stress response system are acting together on different aspects of cognition. Complex phenotypes, such as cognition and memory function are regulated by a complex interplay between different genetic and epigenetic features. We promote the glucocorticoid receptor NR3C1 as a main target to focus in the context of verbal memory and provided a mechanistic concept of the interaction between various biological layers spanning NR3C1 function and its effects on memory. Especially the NR3C1 transcript seemed to be a key element in this complex system.
Free light chains kappa (FLCκ) in cerebrospinal fluid (CSF) are a part of the intrathecal immune response. This observational study was conducted to investigate the effects of different disease-modifying therapies (DMT) on the humoral intrathecal immune response in the CSF of patients with multiple sclerosis (MS). FLCκ were analyzed in CSF and serum samples from MS patients taking DMT (n = 60) and those in a control cohort of treatment-naïve MS patients (n = 90). DMT was classified as moderately effective (including INFß-1a, INFß-1b, glatiramer acetate, dimethyl fumarate, teriflunomide, triamcinolone); highly effective (including fingolimod, daclizumab) and very highly effective (alemtuzumab, natalizumab, rituximab/ocrelizumab, mitoxantrone). FLCκ were measured using a nephelometric FLCκ kit. Intrathecal FLCκ and IgG concentrations were assessed in relation to the hyperbolic reference range in quotient diagrams. Intrathecal FLCκ concentrations and IgG concentrations were significantly lower in samples from the cohort of MS patients taking very highly effective DMT than in samples from the cohort of MS patients taking highly effective DMT and in the treatment-naïve cohort (FLCκ: p = 0.004, p < 0.0001 respectively/IgG: p = 0.013; p = 0.021). The reduction in FLCκ could contribute to an anti-inflammatory effect in the CNS through this mechanism. There was no difference in the appearance of CSF-specific oligoclonal bands (p = 0.830). Longitudinal analyses are required to confirm these results.
Post-COVID-19 syndrome (PCS) has been described as ‘the pandemic after the pandemic’ with more than 65 million people worldwide being affected. The enormous range of symptoms makes both diagnosis complex and treatment difficult. In a post-COVID rehabilitation outpatient clinic, 184 patients, mostly non-hospitalized, received a comprehensive, interdisciplinary diagnostic assessment with fixed follow-up appointments. At baseline, three in four patients reported more than 10 symptoms, the most frequent symptoms were fatigue (84.9%), decreased physical capacity (83.0%), tiredness (81.1%), poor concentration (73.6%), sleeping problems (66.7%) and shortness of breath (67.3%). Abnormalities were found in the mean values of scores for fatigue (FAS = 34.3), cognition (MoCA = 25.5), psychological alterations (anxiety, depression, post-traumatic stress disorder), limitation of lung function (CAT) and severity scores for PCS (PCFS, MCRS). Clinical abnormalities were found in elevated values of heart rate, breathing rate at rest, blood pressure and NT-proBNP levels. As the frequency of the described symptoms decreases only slowly but most often significantly over the course, it is important to monitor the patients over a longer period of time. Many of them suffer from an immense symptom burden, often without pre-existing clinical correlates. Our results show a clear association with objectifiable assessments and tests as well as pronounced symptoms.
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection
(2022)
We analyzed symptoms and comorbidities as predictors of hospitalization in 710 outpatients in North-East Germany with PCR-confirmed SARS-CoV-2 infection. During the first 3 days of infection, commonly reported symptoms were fatigue (71.8%), arthralgia/myalgia (56.8%), headache (55.1%), and dry cough (51.8%). Loss of smell (anosmia), loss of taste (ageusia), dyspnea, and productive cough were reported with an onset of 4 days. Anosmia or ageusia were reported by only 18% of the participants at day one, but up to 49% between days 7 and 9. Not all participants who reported ageusia also reported anosmia. Individuals suffering from ageusia without anosmia were at highest risk of hospitalization (OR 6.8, 95% CI 2.5–18.1). They also experienced more commonly dyspnea and nausea (OR of 3.0, 2.9, respectively) suggesting pathophysiological connections between these symptoms. Other symptoms significantly associated with increased risk of hospitalization were dyspnea, vomiting, and fever. Among basic parameters and comorbidities, age > 60 years, COPD, prior stroke, diabetes, kidney and cardiac diseases were also associated with increased risk of hospitalization. In conclusion, due to the delayed onset, ageusia and anosmia may be of limited use in differential diagnosis of SARS-CoV-2. However, differentiation between ageusia and anosmia may be useful for evaluating risk for hospitalization.
Aims
Sphingosine-1-phosphate (S1P) is a signaling lipid, which is involved in several cellular processes including cell growth, proliferation, migration and apoptosis. The associations of serum S1P levels with cardiac geometry and function are still not clear. We investigated the associations of S1P with cardiac structure and systolic function in a population-based sample.
Methods and results
We performed cross-sectional analyses of 858 subjects (467 men; 54.4%), aged 22 to 81 years, from a sub-sample of the population-based Study of Health in Pomerania (SHIP-TREND-0). We analyzed the associations of serum S1P with structural and systolic function left ventricular (LV) and left atrial (LA) parameters as determined by magnetic resonance imaging (MRI) using sex-stratified multivariable-adjusted linear regression models. In men, MRI data showed that a 1 µmol/L lower S1P concentration was associated with an 18.1 mL (95% confidence interval [CI] 3.66–32.6; p = 0.014) larger LV end-diastolic volume (LVEDV), a 0.46 mm (95% CI 0.04–0.89; p = 0.034) greater LV wall thickness (LVWT) and a 16.3 g (95% CI 6.55–26.1; p = 0.001) higher LV mass (LVM). S1P was also associated with a 13.3 mL/beat (95% CI 4.49–22.1; p = 0.003) greater LV stroke volume (LVSV), an 18.7 cJ (95% CI 6.43–30.9; p = 0.003) greater LV stroke work (LVSW) and a 12.6 mL (95% CI 1.03–24.3; p = 0.033) larger LA end-diastolic volume (LAEDV). We did not find any significant associations in women.
Conclusions
In this population-based sample, lower levels of S1P were associated with higher LV wall thickness and mass, larger LV and LA chamber sizes and greater stroke volume and work of the LV in men, but not in women. Our results indicate that lower levels of S1P were associated with parameters related with cardiac geometry and systolic function in men, but not in women.